Literature DB >> 5298536

Facial paralysis.

H Miller.   

Abstract

Entities:  

Mesh:

Year:  1967        PMID: 5298536      PMCID: PMC1842631          DOI: 10.1136/bmj.3.5569.815

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  7 in total

1.  R OLE OF COMPRESSION IN THE AETIOLOGY OF BELL'S PALSY. AN EXPERIMENTAL STUDY.

Authors:  S N JAIN; A P SHARMA
Journal:  J Laryngol Otol       Date:  1964-03       Impact factor: 1.469

2.  THE PROGNOSIS IN FACIAL PALSY.

Authors:  E P LANGWORTH; D TAVERNER
Journal:  Brain       Date:  1963-09       Impact factor: 13.501

3.  QUANTITATIVE MEASUREMENTS OF THE NASOLACRIMAL REFLEX.

Authors:  K ZILSTORFF-PEDERSEN
Journal:  Arch Otolaryngol       Date:  1965-05

4.  TOPOGNOSIS (TOPOGRAPHIC DIAGNOSIS) OF FACIAL NERVE LESIONS.

Authors:  O JEPSEN
Journal:  Arch Otolaryngol       Date:  1965-05

5.  The prognosis and treatment of spontaneous facial palsy.

Authors:  D TAVERNER
Journal:  Proc R Soc Med       Date:  1959-12

6.  Treatment of acute retrobulbar neuritis with corticotrophin.

Authors:  M D Rawson; L A Liversedge; G Goldfarb
Journal:  Lancet       Date:  1966-11-12       Impact factor: 79.321

7.  Prevention of denervation in Bell's palsy.

Authors:  D Taverner; M E Fearnley; F Kemble; D W Miles; O A Peiris
Journal:  Br Med J       Date:  1966-02-12
  7 in total
  3 in total

Review 1.  [Surgery of the nerves of the neck, nose, and ear region (except Nn. stato-acusticus and olfactorius) (author's transl)].

Authors:  A Miehlke; E Stennert; R Arold; R Chilla; H Penzholz; A Kühner; V Sturm; J Haubrich
Journal:  Arch Otorhinolaryngol       Date:  1981

2.  Identification of adverse reactions to new drugs. IV--Verification of suspected adverse reactions.

Authors:  G R Venning
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-12

3.  Recurrent Bell's palsy. Etiology, frequency, prognosis.

Authors:  B Mamoli; H Neumann; L Ehrmann
Journal:  J Neurol       Date:  1977-09-12       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.